Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photobiomodulation for Aphthous Ulcers in Pediatric Patients
NCT06819033Phase 4Recruiting
- Sponsor
- UTHealth Houston
- Start
- Mar 2025
- Primary completion
- Feb 2026
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by UTHealth Houston. Primary endpoints: Change in Quality of life at 24 hours, Pain as assessed by how frequently patient complains of pain at 24 hours and 1 more. Started Mar 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06819033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06819033.